Metraipolis › archive › dc_ab6da20e482d
Anti-cancer drugs targeting the NADH-binding site of VDAC rewire channel electrophysiology and partially suppress cation selectivity — Europe PMC PMID:41657337
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41657337
- DOI
- 10.1111/febs.70434
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T00:01:04.070Z
- SHA-256 of the archived text
9b211efa49e360744bb9dafe503eecebed74a1f6ef56a02a6cd579e569bfdfa9- Stable URL of this page
https://metraipolis.com/documento/dc_ab6da20e482d
How to cite
Anti-cancer drugs targeting the NADH-binding site of VDAC rewire channel electrophysiology and partially suppress cation selectivity — Europe PMC PMID:41657337 — Europe PMC (en), https://europepmc.org/article/MED/41657337 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab6da20e482d (Metraipolis archive dc_ab6da20e482d, sha256 9b211efa49e360744bb9dafe503eecebed74a1f6ef56a02a6cd579e569bfdfa9)
BibTeX
@misc{dcab6da20e482d,
title = {Anti-cancer drugs targeting the NADH-binding site of VDAC rewire channel electrophysiology and partially suppress cation selectivity — Europe PMC PMID:41657337},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41657337},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab6da20e482d; sha256 9b211efa49e360744bb9dafe503eecebed74a1f6ef56a02a6cd579e569bfdfa9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41657337. Agents can read the archived copy with the MCP tool read_document.